Long-term Clinical Follow-up After PCI for CTO

Long-term Clinical Follow-up After PCI for CTO

The research aimed to evaluate the impact of a successful Percutaneous coronary intervention of chronic total occlusions (CTO-PCI) on long-term MACE (Major Cardiovascular Events), symptoms, survival, Left Ventricular Ejection Fraction (LVEF) and myocardial ischemia up-to-8-years follow-up.

With this observational and prospective study, this research aimed to evaluate the impact of a successful CTO-PCI on long-term MACE (Major Cardiovascular Events), symptoms, survival, LVEF and myocardial ischemia up-to-8-years follow-up.

Inclusion Criteria:

• 18 years or older
• who underwent at least one CTO procedure between 2025 and 2022 in Montpellier University Hospital
• symptomatic of reversible myocardial ischemia
• proof of myocardial viability

Exclusion Criteria:

• refusal of the patient to participate to the study